Form 8-K - Current report:
SEC Accession No. 0001653477-25-000104
Filing Date
2025-08-04
Accepted
2025-08-04 16:27:48
Documents
15
Period of Report
2025-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngvt-20250804.htm   iXBRL 8-K 28306
2 EX-99.1 ex99106302025.htm EX-99.1 451025
6 COMPANY LOGO image1a.jpg GRAPHIC 146914
7 COMPANY LOGO ngvt-20250804_g1.jpg GRAPHIC 146914
  Complete submission text file 0001653477-25-000104.txt   1129145

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngvt-20250804.xsd EX-101.SCH 1882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngvt-20250804_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngvt-20250804_pre.xml EX-101.PRE 12603
18 EXTRACTED XBRL INSTANCE DOCUMENT ngvt-20250804_htm.xml XML 3002
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 251180714
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)